Study: Long COVID ‘brain fog' linked to inflammation, stress markers
(NewsNation) — A new study indicates the debilitating 'brain fog' suffered by millions of long COVID patients is linked to changes in the brain, including inflammation and an impaired ability to rewire itself following COVID-19 infection.
United Press International reported this week that the small-scale study, conducted by researchers at Corewell Health in Grand Rapids, Michigan, and Michigan State University, shows that altered levels of a pair of key brain chemicals could be the culprit.
The study marks the first time doctors have been able to provide scientific proof that validates the experiences of the approximately 12 million COVID 'long-haulers' in the U.S. who have reported neurological symptoms.
Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an anti-inflammatory protein that is crucial to regulating a person's immune system, UPI reported. They also showed lower serum levels of nerve growth factor, a protein vital to the brain's plasticity.
Long COVID cause: Doctor explains three prevailing theories
The study examined 17 COVID-19 patients, including 10 who still experienced symptoms six months after contracting the virus. The most debilitating symptom is brain fog, described by Yale Medicine as 'sluggish' thinking, forgetfulness, difficulty processing information and an inability to focus or concentrate on tasks they used to complete with ease.
The National Library of Medicine describes plasticity as the ability of the brain to change its activity in response to illness or injury. That healing process includes reorganizing the brain's structure, functions or connections.
One of the biggest issues involving long COVID has been doctors' inability to find physical proof of the symptoms described by patients. The study has changed that, according to co-author Dr. Bengt Arnetz.
5 things we know and still don't know about COVID, 5 years after it appeared
'We found biological changes, which I think [is a] very big strength for this study,' Arnetz said, according to UPI. 'In parallel with the effects on executive function, we also saw that [NGF], which reflects the brain's ability to adapt to grow new neurons and connection, was suppressed in long COVID. This is aligned with the findings in the neuro-cognitive test.'
For the neuro-cognitive test, researchers put study participants through a battery of psychological exams. The results were unremarkable for all the exams except one — the 'letter fluency' test.
Arnetz's co-author, clinical neuropsychologist Michael Lawrence, explained that a fluency test measures a person's executive functioning under time constraints. It requires a patient to generate words beginning with a specified letter of the alphabet or to name items from a specific category, like animals or fruit.
Errors or difficulty performing the task are indicative of executive functioning impairments as well as impairments in memory and language. According to the Library of Medicine, similar impairments are found in conditions like Alzheimer's disease, vascular dementia and Lewy body dementia.
Brain fog and other long COVID symptoms affect millions. New treatment studies bring hope
Lawrence said he believes the study is helpful because 'now we have some objective findings that really confirm what patients are describing and feeling.'
Identifying long COVID sufferers through the identified biomarkers could help the medical community develop multidisciplinary treatment for their symptoms, he said.
'I think patients and our medical community, at least years ago, tended to separate the mental health from the physical. But what we know is they're all very interconnected,' Lawrence said. 'The more we can improve mental health-related symptoms, what we see is decreased reports of pain and fatigue. We really need to treat the whole person, but we need to treat it early.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
'Unite for Vets' rally in Washington, D.C., protests cuts in benefits
June 6 (UPI) -- Several thousand veterans converged on the National Mall on Friday to rally against proposed cuts to Veterans Affairs services, among 200 events nationwide. Veterans, military families and others participated in the Unite for Veterans, Unite for America Rally on the 81st anniversary of D-Day, which was the Allies' amphibious invasion of German-occupied France. Veteran-led protests took place at 16 state capitol buildings and more than 100 other places across 43 states. "We are coming together to defend the benefits, jobs and dignity that every generation of veterans has earned through sacrifice," Unite for Veterans said on its website. "Veteran jobs, healthcare, and essential VA services are under attack. We will not stand by." Speakers in Washington included Democrats with military backgrounds: Sen. Tammy Duckworth of Illinois, former Rep. Conor Lamb of Pennsylvania and California Rep. Derek Tran. There were signs against President Donald Trump, VA Secretary Doug Collins and Elon Musk, the multi-billionaire who ran the Department of Government Efficiency. They said those leaders are betraying the country's promises to troops. "Are you tired of being thanked for our service in the public and stabbed in our back in private?" Army veteran Everett Kelly, the national president of the American Federation of Government Employees, asked the crowd. "For years, politicians on both sides of the aisle have campaigned on their support of veterans, but once they get into office, they cut our benefits, our services. They take every opportunity to privatize our health care." The Trump administration plans to cut 83,000 VA staffers and shift more money from the federal health care system to private-sector clinics. The Department of Veterans Affairs employs approximately 482,000 people, including 500,000 workers at 170 hospitals and 1,200 local clinics in the nation's largest health care system. In all, there are 15.8 million veterans, which represents 6.1% of the civilian population 18 years and older. VA officials said the event was misguided. "Anyone who says VA is cutting healthcare and benefits is not being honest," VA press secretary Peter Kasperowicz in a statement to Navy Times. "The Biden Administration failed to address nearly all of VA's most serious problems, including rising health care wait times, benefits backlogs, and major issues with survivor benefits. Under President Trump and Secretary Collins, VA is fixing these problems and making major improvements." The event was modeled after the Bonus Army protests of the 1930s, when veterans who served in World War I gathered in the nation's capital to demand extra pay denied after leaving the service. Irma Westmoreland, a registered nurse working at a VA hospital and the secretary-treasurer of National Nurses United, told the crowd in Washington: "It's important for every person to keep their job, from the engineering staff to the housekeeper to the dietary staff. When cuts are made, the nursing and medical staff will have to pick up all their work that needs to be done."
UPI
an hour ago
- UPI
'Unite for Vets' rally in Washington, D.C., protests cuts in benefits
June 6 (UPI) -- Several thousand veterans converged on the National Mall on Friday to rally against proposed cuts to Veterans Affairs services, among 200 events nationwide. Veterans, military families and others participated in the Unite for Veterans, Unite for America Rally on the 81st anniversary of D-Day, which was the Allies' amphibious invasion of German-occupied France. Veteran-led protests took place at 16 state capitol buildings and more than 100 other places across 43 states. "We are coming together to defend the benefits, jobs and dignity that every generation of veterans has earned through sacrifice," Unite for Veterans said on its website. "Veteran jobs, healthcare, and essential VA services are under attack. We will not stand by." Speakers in Washington included Democrats with military backgrounds: Sen. Tammy Duckworth of Illinois, former Rep. Conor Lamb of Pennsylvania and California Rep. Derek Tran. There were signs against President Donald Trump, VA Secretary Doug Collins and Elon Musk, the multi-billionaire who ran the Department of Government Efficiency. They said those leaders are betraying the country's promises to troops. "Are you tired of being thanked for our service in the public and stabbed in our back in private?" Army veteran Everett Kelly, the national president of the American Federation of Government Employees, asked the crowd. "For years, politicians on both sides of the aisle have campaigned on their support of veterans, but once they get into office, they cut our benefits, our services. They take every opportunity to privatize our health care." The Trump administration plans to cut 83,000 VA staffers and shift more money from the federal health care system to private-sector clinics. The Department of Veterans Affairs employs approximately 482,000 people, including 500,000 workers at 170 hospitals and 1,200 local clinics in the nation's largest health care system. In all, there are 15.8 million veterans, which represents 6.1% of the civilian population 18 years and older. VA officials said the event was misguided. "Anyone who says VA is cutting healthcare and benefits is not being honest," VA press secretary Peter Kasperowicz in a statement to Navy Times. "The Biden Administration failed to address nearly all of VA's most serious problems, including rising health care wait times, benefits backlogs, and major issues with survivor benefits. Under President Trump and Secretary Collins, VA is fixing these problems and making major improvements." The event was modeled after the Bonus Army protests of the 1930s, when veterans who served in World War I gathered in the nation's capital to demand extra pay denied after leaving the service. Irma Westmoreland, a registered nurse working at a VA hospital and the secretary-treasurer of National Nurses United, told the crowd in Washington: "It's important for every person to keep their job, from the engineering staff to the housekeeper to the dietary staff. When cuts are made, the nursing and medical staff will have to pick up all their work that needs to be done."
Yahoo
an hour ago
- Yahoo
Long-lasting HIV prevention shot heads toward approval
June 6 (UPI) -- A new vaccine to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month. If approved, the shot -- lenacapavir -- would be given twice a year and could be a big step forward in the fight against HIV. Drugmaker Gilead Sciences tested the shot in a study of women and girls. None of the participants who received the injections got HIV. That early success helped boost Gilead's stock by 73% over the past year, The Wall Street Journal reported. "We know it's challenging to take a daily pill for prevention, and we see an incredible opportunity here," said Johanna Mercier, Gilead's chief commercial officer Right now, more than 400,000 people in the United States use pills to prevent HIV, The Wall Street Journal added. These medications are referred to as PrEP, short for pre-exposure prophylaxis. Gilead expects the number of users to top 1 million by the next decade. Many people already say they'd prefer a shot over daily pills. In one survey of more than 500 PrEP users, 95% said they would switch to a long-acting injection. Sales of other long-acting options, like the shot Apretude from GSK, have risen sharply - up 63% in the past year. Even with strong results, Gilead faces several hurdles. One is reaching the people who need PrEP the most. Black Americans represent 39% of new HIV cases but only 14% of current PrEP users. Many people still face stigma or lack insurance coverage, which can limit access. Gilead says reaching underserved groups is a top goal. Most current PrEP users have commercial insurance, but Medicaid will be key for expanding access to lower-income communities. Another concern: Some experts worry the new shot may simply replace current Gilead products, like the daily pill Descovy, which now holds about 40% to 45% of the market. But Gilead says the shot should help expand the overall number of people using PrEP in both the U.S. and abroad. "We're thinking globally about the public health impact we can have," Mercier said. The company is working with governments and health groups in the United Kingdom and low-income countries to raise awareness and make these products more available. More information The National Institutes of Health has more on Pre-Exposure Prophylaxis (PrEP). Copyright © 2025 HealthDay. All rights reserved.
